A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B
Background. Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis B (CHB) are both the most common underlying diseases leading to cirrhosis and hepatocellular carcinoma, and NAFLD and HBV infection are the first and second leading causes of chronic liver disease in China. However, there are...
Saved in:
| Main Authors: | Yandong Chen, Qiang Liu, Jing Han, Siyu Gao, Qian Xiao, Xiaoli Huang, Lu Lu, xiaolin Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Emergency Medicine International |
| Online Access: | http://dx.doi.org/10.1155/2022/4774195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retracted: A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B
by: Emergency Medicine International
Published: (2023-01-01) -
Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease
by: Hua Jiang, et al.
Published: (2024-12-01) -
Corrigendum: Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease
by: Hua Jiang, et al.
Published: (2025-04-01) -
Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01) -
Biomarkers in Nonalcoholic Fatty Liver Disease
by: Manuela G Neuman, et al.
Published: (2014-01-01)